Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Sortase-catalyzed in vitro functionalization of a HER2-specific recombinant Fab for tumor targeting of the plant cytotoxin gelonin.

Kornberger P, Skerra A.

MAbs. 2014 Mar-Apr;6(2):354-66. doi: 10.4161/mabs.27444. Epub 2013 Dec 9.

PMID:
24492291
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The functionalized human serine protease granzyme B/VEGF₁₂₁ targets tumor vasculature and ablates tumor growth.

Mohamedali KA, Cao Y, Cheung LH, Hittelman WN, Rosenblum MG.

Mol Cancer Ther. 2013 Oct;12(10):2055-66. doi: 10.1158/1535-7163.MCT-13-0165. Epub 2013 Jul 15.

PMID:
23858102
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Fusion toxin BLyS-gelonin inhibits growth of malignant human B cell lines in vitro and in vivo.

Luster TA, Mukherjee I, Carrell JA, Cho YH, Gill J, Kelly L, Garcia A, Ward C, Oh L, Ullrich SJ, Migone TS, Humphreys R.

PLoS One. 2012;7(10):e47361. doi: 10.1371/journal.pone.0047361. Epub 2012 Oct 9.

PMID:
23056634
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles.

Zhang F, Huang X, Zhu L, Guo N, Niu G, Swierczewska M, Lee S, Xu H, Wang AY, Mohamedali KA, Rosenblum MG, Lu G, Chen X.

Biomaterials. 2012 Jul;33(21):5414-22. doi: 10.1016/j.biomaterials.2012.04.032. Epub 2012 May 3.

PMID:
22560667
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Gadolinium metallofullerenol nanoparticles inhibit cancer metastasis through matrix metalloproteinase inhibition: imprisoning instead of poisoning cancer cells.

Meng H, Xing G, Blanco E, Song Y, Zhao L, Sun B, Li X, Wang PC, Korotcov A, Li W, Liang XJ, Chen C, Yuan H, Zhao F, Chen Z, Sun T, Chai Z, Ferrari M, Zhao Y.

Nanomedicine. 2012 Feb;8(2):136-46. doi: 10.1016/j.nano.2011.08.019. Epub 2011 Sep 17.

PMID:
21930111
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Cytotoxicity of VEGF(121)/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2.

Mohamedali KA, Ran S, Gomez-Manzano C, Ramdas L, Xu J, Kim S, Cheung LH, Hittelman WN, Zhang W, Waltenberger J, Thorpe PE, Rosenblum MG.

BMC Cancer. 2011 Aug 17;11:358. doi: 10.1186/1471-2407-11-358.

PMID:
21849059
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.

Mohamedali KA, Li ZG, Starbuck MW, Wan X, Yang J, Kim S, Zhang W, Rosenblum MG, Navone NM.

Clin Cancer Res. 2011 Apr 15;17(8):2328-38. doi: 10.1158/1078-0432.CCR-10-2943. Epub 2011 Feb 22.

PMID:
21343372
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Multiplexed PET probes for imaging breast cancer early response to VEGF₁₂₁/rGel treatment.

Yang M, Gao H, Sun X, Yan Y, Quan Q, Zhang W, Mohamedali KA, Rosenblum MG, Niu G, Chen X.

Mol Pharm. 2011 Apr 4;8(2):621-8. doi: 10.1021/mp100446t. Epub 2011 Feb 15.

PMID:
21280671
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor.

Ali MA, Choy H, Habib AA, Saha D.

Neoplasia. 2007 May;9(5):370-81.

PMID:
17534442
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A review of the past, present, and future directions of neoplasia.

Rehemtulla A, Ross BD.

Neoplasia. 2005 Dec;7(12):1039-46. Review. No abstract available.

PMID:
16354585
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors.

Mohamedali KA, Kedar D, Sweeney P, Kamat A, Davis DW, Eve BY, Huang S, Thorpe PE, Dinney CP, Rosenblum MG.

Neoplasia. 2005 Oct;7(10):912-20.

PMID:
16242074
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk